The round was co-led by McKesson Ventures and Health Velocity Capital with participation from existing institutional investor Nueterra Capital alongside new investor CrimsoNox Capital.
The company intends to use the funds to accelerate the expansion of its physical footprint of infusion centers in existing markets while simultaneously entering new markets across the country.
Led by Doug Ghertner, CEO, IVX Health is a provider of infusion and injection therapy for those with complex chronic conditions such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis and other conditions.
The company’s centers are located in the communities where patients live and offer flexible scheduling, including evenings and weekends. Patients can relax in their own private suite, equipped with high-speed Wi-Fi, a flat screen TV, and comfortable recliners with room for guests.
The centers operate under the name and brand Infusion Express in Kansas City, Philadelphia, Chicago, and San Francisco with plans to open in Nashville, TN, Harrisburg, PA, and Columbus, OH in the coming months.
IVX Health will further expand into additional markets in 2020.
FinSMEs
05/08/2019